A
Artelo Biosciences
ARTLClinical-stage biopharmaceutical company (Nasdaq: ARTL)
Market Performance
Tokenized Assets
| Ticker | Exchange | Price | 24H | Spread | Liquidity ±2% | 24H Volume | OI | Funding | Max Leverage | Fees |
|---|
Clinical-stage biopharmaceutical company (Nasdaq: ARTL)
| Ticker | Exchange | Price | 24H | Spread | Liquidity ±2% | 24H Volume | OI | Funding | Max Leverage | Fees |
|---|